VIVARA S.A. (VIVA3) Main Indicators
Basic Data - VIVA3
| Company | VIVARA S.A. |
| Corporate Name | VIVARA PARTICIPAÇOES S.A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Participação em outras sociedades. na qualidade de quotistas. ou acionistas; holding de instituições não-financeiras; e agente de propriedade intelectual. |
| Share | VIVA3 |
| Quote Date | 11/08/2024 |
| Share Type | ON |
| Last Closing | R$ 25.58 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 180.98 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Consumo Cíclico |
| Subsector | Tecidos. Vestuário e Calçados |
| Segment | Acessórios |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICON, IGC, IGCT, IGNM, INDX, ITAG, IVBX, SMLL |
| Updated 11/09/2024 | |
Relative Prices - VIVA3
| Price/Earnings | 12.13 |
| Price/SBV | 2.65 |
| Price/Net Sales | 2.47 |
| Price/CFO | 13.28 |
| Price/FCF | 17.61 |
| Price/Total Assets | 1.67 |
| Price/EBIT | 10.78 |
| Price/Working Capital | 4.06 |
| Price/NCAV | 36.96 |
| EV/EBIT | 10.66 |
| EV/EBITDA | 8.30 |
| EV/Net Sales | 2.45 |
| EV/CFO | 13.13 |
| EV/FCF | 17.41 |
| EV/Total Assets | 1.66 |
| Company Market Cap | R$ 6.04 B |
| Enterprise Value | R$ 5.97 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 25.58 |
| Share Price Date | 11/08/2024 |
| Dividend Yield | 1.46% |
| Updated 11/09/2024 | |
Income Statement - VIVA3
| Net Revenue | R$ 2.44 B |
| Gross Result | R$ 1.68 B |
| EBIT | R$ 560.45 M |
| Depreciation and Amortization | - R$ 159.29 M |
| EBITDA | R$ 719.74 M |
| Net Profit | R$ 498.09 M |
| Net Profit/Share | R$ 2.11 |
| Updated 11/07/2024 | |
| Net Revenue | R$ 562.90 M |
| Gross Result | R$ 376.71 M |
| EBIT | R$ 106.25 M |
| Depreciation and Amortization | - R$ 43.45 M |
| EBITDA | R$ 149.69 M |
| Net Profit | R$ 107.17 M |
| Profit/Share | R$ 0.45 |
| Updated 11/07/2024 | |
Price and Volume Behavior - VIVA3
| Lowest Price 52 weeks | R$ 19.83 |
| Highest Price 52 weeks | R$ 35.03 |
| Variation 2024 | -23.57% |
| Variation 1 year | -4.62% |
| Variation 2 years(total) | 4.17% |
| Variation 2 years(yearly) | 2.06% |
| Variation 3 years(total) | -1.56% |
| Variation 3 years(yearly) | -0.52% |
| Variation 4 years(total) | 13.66% |
| Variation 4 years(yearly) | 3.25% |
| Variation 5 years(total) | 14.28% |
| Variation 5 years(yearly) | 2.70% |
| Average Daily Volume (3 months) | R$ 83.96 M |
| Updated 11/09/2024 | |
Returns and Margins - VIVA3
| Return on Initial Tangible Capital | 15.02% |
| Return on Initial Invested Capital | 17.77% |
| Pre-Tax Return on Initial Tangible Capital | 22.76% |
| Pre-Tax Return on Initial Invested Capital | 26.93% |
| Return on Initial Shareholder´s Equity | 26.54% |
| Return on Initial Asset | 16.48% |
| Gross Margin | 68.63% |
| Net Margin | 20.40% |
| EBIT Margin | 22.95% |
| EBITDA Margin | 29.47% |
| Initial Asset Turnover | 0.81 |
| Financial Leverage | 1.58 |
| Liabilities/Net Worth | 0.58 |
| Net Debt/EBITDA | -0.09 |
| Updated 11/07/2024 | |
Balance Sheet - VIVA3
| Cash and Cash Equivalents | R$ 298.90 M |
| Total Assets | R$ 3.61 B |
| Short-Term Debt | R$ 140.97 M |
| Long-Term Debt | R$ 90.00 M |
| Gross Debt | R$ 230.97 M |
| Net Debt | - R$ 67.93 M |
| Shareholder´s Equity | R$ 2.28 B |
| Share Book Value | R$ 9.66 |
| Common Shares | 236,197,769 |
| Preferred Shares | 0 |
| Total | 236,197,769 |
| Common Shares in Treasury | 1,221,419 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,221,419 |
| Common Shares (Except Treasury) | 234,976,350 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 234,976,350 |
| Updated 11/07/2024 | |
Cash Flow - VIVA3
| Operating Cash Flow | R$ 454.83 M |
| Cash Flow from Investments | - R$ 14.80 M |
| Financing Cash Flow | - R$ 210.65 M |
| Increase (Reduction) in Cash and Equivalents | R$ 229.38 M |
| Updated 11/07/2024 | |
| Operating Cash Flow | R$ 20.18 M |
| Cash Flow from Investments | R$ 19.43 M |
| Financing Cash Flow | - R$ 14.82 M |
| Increase (Reduction) in Cash and Equivalents | R$ 24.78 M |
| Updated 11/07/2024 | |
Experimental - VIVA3
| CAPEX 3 months | - R$ 24.60 M |
| Free Cash Flow 3 months | - R$ 4.42 M |
| CAPEX 12 months | - R$ 111.73 M |
| Free Cash Flow 12 months | R$ 343.11 M |
| Updated 11/07/2024 | |